{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/abbvie-announces-positive-phase-3-results-for-epcoritamab-plus-lenalidomide-in-patients-with-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-302813689.html", "message": "News view counter 821258 successfully enlarged"}